| Relates to tumour types | Title of Research | Description | More information |
|---|---|---|---|
| Anaplastic astrocytoma |
UKCRN ID 7007 NCRN064 SAPPHIRE - AP 12009 vs Temozolomide or BCNU in anaplastic astrocytoma | Interventional: drug Efficacy and safety of Trabedersen (AP 12009) in adult patients with recurrent or refactory anaplastic astrocytoma (WHO grade III) as compared to... read more | |
| Anaplastic astrocytoma |
EORTC protocol 26053-22054 (BR14): A randomised controlled trial of temozolomide as adjuvant or concurrent treatment in anaplastic (WHO grade III) glioma | Interventional: chemo and radiotherapiesThis study will establish whether concurrent RT and adjuvant temozolomide improves the outcome of patients with non-codeleted... read more | |
| Meningioma |
EORTC protocol 22042-26042. Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a Phase II and observation study | Interventional: radiotherapy For malignant meningiomas. Radiotherapy dose will be escalated to 60 or 70Gy depending on the extent of resection and amount of residual... read more | |
| Glioblastoma |
Phase I trial of IMA950 multipeptide vaccine plus GMCSF in glioblastoma | Interventional: drug A Cancer Research UK Phase I trial of IMA950 (a novel multi-peptide vaccine) plus GM-CSF in patients with newly diagnosed glioblastoma. read more | |
| Glioblastoma |
NCT01310868 GALA5. Study of Polifeprosan 20 With Carmustine Implant (Gliadel) and fluorescence-guided radical tumour resection with Aminolevulinic Acid followed by adjuvant radiotherapy and Temozolomide in patients with primary glioblastoma. | Interventional: chemo and radiotherapy Drugs used in chemotherapy, such as Gliadel wafer and temozolomide, work in different ways to stop the growth of tumor cells,... read more | |
| Glioblastoma |
NCT01233492 Boron Phenylalanine with or without Mannitol in treating patients with Glioblastoma Multiforme | Interventional: drug. Giving boron phenylalanine in different ways and measuring it in tissue in patients with glioblastoma multiforme may help in planning better... read more | |
| Glioblastoma |
NCT01308684 A dose and efficacy study of RO5323441 in combination with Avastin (Bevacizumab) in patients with recurrent glioblastoma | Interventional: drug. This study will evaluate the safety and efficacy of RO5323441 in combination with Avastin (bevacizumab) in patients with recurrent... read more | |
| Medulloblastoma |
A dose finding and safety study of Oral LDE225 in children | Interventional: drug. This study is to decide what the maximum tolerated dose of LDE225 is and to characterise the limiting toxicities of LDE225 read more | |
| Glioma |
CNS 2004 03 Cooperative multicentre study for children and adolescents with low grade glioma. | Interventional: chemo. This trial is looking at chemotherapy and radiotherapy for children and young people with a 'low grade' tumour. If possible, children and... read more | |
| Glioblastoma |
CRUKD/11/006: OPERATIC A Cancer Research UK Trial of olaparib (AZD2281), an oral PARP inhibitor, combined with extended low-dose oral temozolomide in patients with relapsed glioblastoma | Interventional: drug. The aims of this study of AZD2281 in combination with extended, daily low-dose temozolomide in patients with recurrent GBM is proposed are... read more | |
| Glioma |
CNS 2007 13 Translational Study for Children and Adolescents with Low Grade Glioma | Observational. This study is looking at the family histories of children and young people who have been diagnosed with a low grade glioma. Researchers are trying to... read more | |
| Glioblastoma |
ISRCTN62033854 Magnetic resonance imaging to characterise invasive phenotypes in cerebral gliomas: an observational prospective cohort study | An observational study using imaging. The spectrum of high grade gliomas invasion can be identified using diffusion tensor imaging (DTI). Combining these findings... read more | |
| Glioblastoma |
DORIC - Phase II trial of cediranib +/- gefitinib for recurrent glioblastoma | Interventional: drug. This is a randomised, double blind placebo controlled study in patients with recurrent or progressive glioblastoma (WHO grade IV). Patients are... read more | |
| Glioma |
CRUK/07/032: BR13: Primary chemotherapy with temozolomide vs radiotherapy in patients with low-grade gliomas after stratification for genetic 1p loss: a phase III study (EORTC 22033-26033) | A randomized study to demonstrate a difference in progression-fre survival (PFS) for primary treatment with temozolomide in order to assess: whether PFS and overall... read more | |
| Glioblastoma |
NCT00977431 Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiforme | Interventional: drug and radiotherapy. This study is an open label trial to determine the Maximum Tolerated Dose (MTD), safety, pharmacokinetics, and efficacy of BIBW... read more | |
| Glioblastoma |
Dose-Escalation Study of Carboplatin Administration Into the Brain for Glioblastoma Multiforme NCT01317212 | This is a phase 1 trial. Laboratory studies demonstrate that glioma tumour cells are sensitive to a number of different chemotherapies, including carboplatin. When... read more | |
| Ependymoma |
Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma (PETEY) NCT01032070 | This is a phase 2 study to evaluate the efficacy of single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma. It is... read more | |
| Meningioma Glioma |
A study to see if a type of MRI scan can help doctors planning surgery to treat brain tumours | Observational. The main aim of this study is to see how useful fMRI is to map parts of the brain. Researchers want to test a new way of finding out whether the tumour... read more | |
| Anaplastic astrocytoma Anaplastic glioma Anaplastic oligodendroglioma Astrocytoma Glioblastoma Glioma Medulloblastoma Meningioma |
UKCRN ID 9977 An Evaluation of a Patient Information Navigation Service: Informing and involving newly diagnosed malignant brain tumour and colorectal cancer patients in their cancer health care using a Patient Information Navigator. | For Scottish patients, this study utilises the decision model already piloted in the Edinburgh Cancer Centre with Breast and Prostate Cancer patients. This model... read more | |
| Anaplastic oligodendroglioma Astrocytoma Glioma Medulloblastoma Meningioma |
MREC - 07/MRC10/11 National Brain Tumour Study (NBT) | Observational. The purpose of the National Brain Tumour Study (NBT) this study is to establish a DNA resource from individuals and families with brain tumours,... read more | |
| Glioblastoma |
Phase 1 clinical trial of olaparib with temozolomide in recurrent glioblastoma | In this trial, they are looking at a drug called olaparib which is a biological therapy called a PARP inhibitor. PARP is an enzyme that helps damaged cells to repair... read more |